Grantham, Mayo, Van Otterloo & Co (GMO)’s Quanex NX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,300
Closed -$243K 729
2023
Q1
$243K Sell
11,300
-900
-7% -$21.6K ﹤0.01% 632
2022
Q4
$289K Buy
+12,200
New +$274K ﹤0.01% 636
2022
Q1
Sell
-9,700
Closed -$240K 747
2021
Q4
$240K Sell
9,700
-39,900
-80% -$890K ﹤0.01% 658
2021
Q3
$1.06M Buy
49,600
+23,500
+90% +$549K 0.01% 523
2021
Q2
$648K Buy
26,100
+2,900
+13% +$77.3K ﹤0.01% 582
2021
Q1
$609K Buy
23,200
+5,600
+32% +$140K ﹤0.01% 667
2020
Q4
$390K Sell
17,600
-18,000
-51% -$370K ﹤0.01% 717
2020
Q3
$656K Sell
35,600
-8,300
-19% -$132K ﹤0.01% 587
2020
Q2
$609K Buy
43,900
+33,700
+330% +$401K ﹤0.01% 604
2020
Q1
$103K Sell
10,200
-16,100
-61% -$257K ﹤0.01% 727
2019
Q4
$449K Sell
26,300
-48,300
-65% -$909K ﹤0.01% 602
2019
Q3
$1.35M Buy
74,600
+2,400
+3% +$43.1K 0.01% 502
2019
Q2
$1.36M Buy
72,200
+55,800
+340% +$936K 0.01% 495
2019
Q1
$261K Buy
+16,400
New +$260K ﹤0.01% 656

Other funds holding NX

Grantham, Mayo, Van Otterloo & Co (GMO)'s NX Position: Q2 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Quanex (NX) in Q2 2023, closing a stake of 11,300 shares — an estimated $243K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NX in Q1 2019 and held it in 14 quarters. The position peaked at $1.36M in Q2 2019. 159 funds tracked by Wall St. Rank hold NX as of Q2 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Quanex position as of Q2 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,300 Quanex shares in Q2 2023, an estimated $243K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Quanex in Q1 2019 and held it in 14 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Quanex position peaked at $1.36M in Q2 2019.
  • 159 funds tracked by Wall St. Rank held Quanex as of Q2 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.